[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351916-105":59,"doc-detail-351916-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","evaluation-and-expression-level-verification-of-the-prognostic-value-of-palmitoylation-related-genes-in-ovarian-cancer","Evaluation and expression-level verification of the prognostic value of palmitoylation-related genes in ovarian cancer","","Ovarian cancer remains highly lethal, while protein S-palmitoylation has been linked to tumor progression but lacks clear functional and mechanistic clarification in OC. This study defines palmitoylation-related genes (PRGs) as those encoding palmitoylation/depalmitoylation enzymes and genes regulated by this modification. PRGs were mined from public transcriptomic datasets; intersecting OC-related and palmitoylation-linked DEGs yielded biomarkers. A prognostic risk model was built on TCGA-OV and validated in GSE51088, integrated into a nomogram, and characterized by pathway, immune, checkpoint, drug, and mutation analyses. RT-qPCR in clinical samples validated HSPG2, SCGB1D2, BRD4 upregulation and RARRES1 downregulation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluation-and-expression-level-verification-of-the-prognostic-value-of-palmitoylation-related-genes-in-ovarian-cancer/351916/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluation-and-expression-level-verification-of-the-prognostic-value-of-palmitoylation-related-genes-in-ovarian-cancer/351916.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How were palmitoylation-related genes (PRGs) defined in this study?","Question",{"text":113,"@type":114},"PRGs were defined as genes encoding enzymes directly involved in palmitoylation/depalmitoylation and genes whose functions, subcellular localization, or signaling are regulated by this modification.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What cohorts were used to build and validate the prognostic risk model?",{"text":118,"@type":114},"The model was constructed using the TCGA-OV cohort (N=378) and validated in the GSE51088 cohort (N=152).",{"name":120,"@type":111,"acceptedAnswer":121},"Which biomarkers and expression directions were confirmed by RT-qPCR?",{"text":122,"@type":114},"RT-qPCR validation showed upregulation of HSPG2, SCGB1D2, and BRD4, and downregulation of RARRES1 in ovarian cancer tissues, consistent with bioinformatic predictions (P\u003C0.05).","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351916,1790127718,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nEvaluation and expression-level verification of the prognostic value of palmitoylation-related genes in ovarian cancer  \nQiang Huang1,2, Min He1,2, Ting Cao1, ChunyanChen1, Peng Zhou1, Zhongyan Liu1 & Rongkai Xie1􀀍  \nOvarian cancer (OC) remains the most lethal malignancy within the spectrum of gynecological cancers globally. While protein S-palmitoylation has been extensively implicated in tumor progression, its specific functional contributions and molecular mechanisms in the context of OC pathogenesis remain to be fully elucidated. This article aims to explore the prognostic effect associated with palmitoylationin OC. In this study, palmitoylation-related genes (PRGs) were defined as genes encoding enzymes directly involved in the palmitoylation/depalmitoylation process, as well as genes whose functions, subcellular localization, or signaling are regulated by this modification. Based on this definition, PRGs comprising enzymes and regulated substrates, were identified from public transcriptomic databases. By intersecting ovarian cancer (OC)-associated and palmitoylation-linked differentially expressed genes (DEGs), candidate targets were pinpointed. A prognostic risk model was then constructed using LASSO and Cox regression analyses on theTCGA-OV cohort (N = 378) and validated in the GSE51088 cohort (N = 152). This model was integrated into a predictive nomogram and further characterized through pathway enrichment, immune infiltration, checkpoint analysis, drug screening, and mutation profiling. Finally, identified markers were validated via RT-qPCR in clinical samples. Through intersecting DEGs1 and DEGs2, we obtained 24 candidate biomarkers. Four PRGs (HSPG2, BRD4, RARRES1, and SCGB1D2) were identified to construct a prognostic risk model. The risk score, alongside ethnicity and tumor stage, served as an independent prognostic indicator, integrated into a robust nomogram. Mechanistically, high-risk cohorts were characterized by dysregulated ribosome and translation initiation pathways, altered infiltration of seven immune cell types, and significant variations in seven checkpoints (e.g., CTLA4, CD274). Additionally, the model predicted sensitivities for 131 drugs and captured a highTP53 mutation rate. RT-qPCR validation confirmed the upregulation of HSPG2, SCGB1D2, and BRD4, and the downregulation of RARRES1 in OCtissues, showing high consistency with bioinformatic predictions (P \u003C 0.05). This study identified HSPG2, BRD4, RARRES1, and SCGB1D2, which served as prognostic markers reflecting the palmitoylation-related biological landscape in OC that could lay the foundation for innovative therapeutic strategies.  \nKeywords Ovarian cancer, Palmitoylation related genes, Prognostic genes, Independent prognostic factors  \nWorldwide, Ovarian cancer (OC) exhibits the highest incidence rate among gynecological malignant tumorsand contributes substantially to global cancer-related mortality in females, holding an eighth-ranking position in terms of cancer-associated fatalities1,2. As reported in Hong Kong, China, the incidence rate was 11.5/100,000 in 20233. Clinically, OC manifests as a heterogeneous malignancy characterized by varied pathobiological behaviors and molecular subgroups that translate into distinct clinical trajectories. The majority of ovarian cancer pathologic types are of epithelial origin (90%), among which the high-grade serous subtype contributes to 70–80% of all mortality cases, while 70% of ovarian cancer is identified as advanced disease when diagnosed, with the lack of clinical manifestations. Following cytoreductive surgery combined with platinum-based chemotherapy, 70% of patients are still likely to develop metastasis within a 2–3 year period4. Despite the application of poly-ADP-ribose polymerase (PARP) inhibitors and angiogenesis blockers like bevacizumab as maintenance therapies, outcomes for advanced and recurrent cases re","cbCaiv1IQg0xCfGx","https://ap.wps.com/l/cbCaiv1IQg0xCfGx","pdf",3655128,21,"English","# Introduction\n## Background on ovarian cancer and unmet clinical needs\n## Role of palmitoylation and PRGs in cancer biology\n# Methods and analysis approach\n## Definition and identification of palmitoylation-related genes\n## DEG intersection to obtain candidate biomarkers\n## Construction and validation of a prognostic risk model\n# Results\n## Prognostic risk model, nomogram integration, and independence\n## Mechanistic and immunological characterization\n## Drug sensitivity, mutation profiling, and checkpoint analysis\n## RT-qPCR validation in clinical samples\n# Conclusion","[{\"question\":\"How were palmitoylation-related genes (PRGs) defined in this study?\",\"answer\":\"PRGs were defined as genes encoding enzymes directly involved in palmitoylation/depalmitoylation and genes whose functions, subcellular localization, or signaling are regulated by this modification.\"},{\"question\":\"What cohorts were used to build and validate the prognostic risk model?\",\"answer\":\"The model was constructed using the TCGA-OV cohort (N=378) and validated in the GSE51088 cohort (N=152).\"},{\"question\":\"Which biomarkers and expression directions were confirmed by RT-qPCR?\",\"answer\":\"RT-qPCR validation showed upregulation of HSPG2, SCGB1D2, and BRD4, and downregulation of RARRES1 in ovarian cancer tissues, consistent with bioinformatic predictions (P\\u003c0.05).\"}]","Evaluation and expression-level verification of the prognostic value of palmitoylation-related genes in ovarian cancer | PDF",1790096500,53,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d0d46bca11843aefcbc255a5bb92d81f.webp",983,1291,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61532e55e7a37e0ae373e0e50aa2efb7.webp",982,1290,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b2fd3216dd89b6d87a672623ff7d2dbf.webp",981,1289,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0ceb27748cc73a2037892a51c7e8f4a0.webp",980,1287]